Literature DB >> 28185081

[Electrophysiologic procedure complications in the elderly].

Dietrich Pfeiffer1, Martin Neef2, Daniel Jurisch2, Andreas Hagendorff2.   

Abstract

Published registries give limited information on age-dependent complication rates. There are several reasons for this, including limited numbers of patients in subgroups (e.g., contractility management), experience-dependent procedures (e.g., catheter ablation), or in changing indications (e.g., resynchronization). Finally, severely ill and very old patients with limited prognosis are often excluded from electrophysiologic procedures. Therefore, published data are difficult to interpret. Meta-analyses of randomized trials give more precise information on included patient cohorts, but do not necessarily reflect daily practice because elderly patients are often excluded from trials. Therefore, the individual risk of elderly patients has to be estimated on an individual case basis. In summary, the age of patients is not relevant regarding possible complications; thus, there is no age limit for electrophysiologic interventions. Therefore, there is no alternative to the individual estimation of procedural risks of interventions of an informed patient by an experienced cardiologist.

Entities:  

Keywords:  Catheter ablation; Geriatrics; Informed consent; Pacemaker, artificial; Resynchronization

Mesh:

Year:  2017        PMID: 28185081     DOI: 10.1007/s00399-017-0486-2

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  27 in total

1.  Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States.

Authors:  Vivian Tsai; Mary K Goldstein; Henry H Hsia; Yongfei Wang; Jeptha Curtis; Paul A Heidenreich
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-08-30

2.  Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain.

Authors:  Johannes B van Rees; C Jan Willem Borleffs; Joep Thijssen; Mihály K de Bie; Lieselot van Erven; Suzanne C Cannegieter; Jeroen J Bax; Martin J Schalij
Journal:  Europace       Date:  2011-09-13       Impact factor: 5.214

3.  Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Authors:  Riccardo Cappato; Hugh Calkins; Shih-Ann Chen; Wyn Davies; Yoshito Iesaka; Jonathan Kalman; You-Ho Kim; George Klein; Andrea Natale; Douglas Packer; Allan Skanes; Federico Ambrogi; Elia Biganzoli
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12-07

4.  The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators.

Authors:  Matthew R Reynolds; David J Cohen; Aaron D Kugelmass; Phillip P Brown; Edmund R Becker; Steven D Culler; April W Simon
Journal:  J Am Coll Cardiol       Date:  2006-05-30       Impact factor: 24.094

5.  A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.

Authors:  Alan Kadish; Koonlawee Nademanee; Kent Volosin; Steven Krueger; Suresh Neelagaru; Nirav Raval; Owen Obel; Stanislav Weiner; Marc Wish; Peter Carson; Kenneth Ellenbogen; Robert Bourge; Michael Parides; Richard P Chiacchierini; Rochelle Goldsmith; Sidney Goldstein; Yuval Mika; Daniel Burkhoff; William T Abraham
Journal:  Am Heart J       Date:  2011-02       Impact factor: 4.749

6.  Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation.

Authors:  Jonathan P Piccini; Moritz F Sinner; Melissa A Greiner; Bradley G Hammill; João D Fontes; James P Daubert; Patrick T Ellinor; Adrian F Hernandez; Allan J Walkey; Susan R Heckbert; Emelia J Benjamin; Lesley H Curtis
Journal:  Circulation       Date:  2012-09-26       Impact factor: 29.690

Review 7.  Catheter ablation for paroxysmal and persistent atrial fibrillation.

Authors:  Huai Sheng Chen; Jun Min Wen; Sheng Nan Wu; Jian Ping Liu
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

8.  Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials.

Authors:  Jonathan P Piccini; Renato D Lopes; Melissa H Kong; Vic Hasselblad; Kevin Jackson; Sana M Al-Khatib
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12

9.  Survival after implantable cardioverter-defibrillator implantation in the elderly.

Authors:  Derek Yung; David Birnie; Paul Dorian; Jeffrey S Healey; Christopher S Simpson; Eugene Crystal; Andrew D Krahn; Yaariv Khaykin; Douglas Cameron; Zhongliang Chen; Douglas S Lee
Journal:  Circulation       Date:  2013-06-18       Impact factor: 29.690

10.  Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005.

Authors:  Sana M Al-Khatib; Melissa A Greiner; Eric D Peterson; Adrian F Hernandez; Kevin A Schulman; Lesley H Curtis
Journal:  Circ Arrhythm Electrophysiol       Date:  2008-10
View more
  1 in total

1.  CIED implantation in elderly patients: a single-center experience.

Authors:  Nikolay N Ilov; Anatoly A Nechepurenko; Albert M Abdulkadyrov; Damir R Paskeev; Timur F Asfandiyarov; Dmitry G Tarasov
Journal:  J Geriatr Cardiol       Date:  2018-06       Impact factor: 3.327

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.